Bioactive Materials Market Size, Share and COVID-19 Impact Analysis, By Material (Glass, Ceramics, Composites, and Others), By Application (Orthopaedics, Dentistry, Pharmaceuticals & Biotechnology, and Others), and Regional Forecast, 2025-2032

Bioactive materials exhibit biological responses and help in curing and maintaining the normal physiological condition of the living system. These materials are devoid of any negative impact on the living system. The biological response elicited by the bioactive materials enables it to form a bond with the tissue. Bioactive materials like glass, ceramics, composites and others are being increasingly used in orthopedics, dentistry, pharmaceuticals & biotechnology, and other applications. Rapid developments in the field of medicine and healthcare are the key drivers for the global bioactive materials market.  

Research and development in the field of medical sciences have resulted in the development of good surgical procedures and treatment practices for the restoration of the normal functioning of different organ systems. This caused the increased acceptance of different surgeries and treatments by patients in different age groups. Along with this, the increasing geriatrics population and rising demand for tissue replacement are also significant factors contributing to the growth of the global bioactive materials market.  An increasing number of patients taking dental treatments such as permanent restoration of teeth, root canals, mineralization of teeth, etc. are anticipated to play a significant role in the growth of the global market in the near future.

The high cost involved in the production and processing of bioactive materials is anticipated to hinder the smart polymers market growth. Bioactive materials are needed to be processed with proper care to meet the required standards and properties. To make them effective in desired applications, manufacturing bioactive materials involves the use of advanced tools and technology making their production costlier.

Impact of COVID-19 on the Bioactive Materials Market

The outbreak of the COVID-19 pandemic has resulted in a temporary lockdown and restrictions on movement. This caused a decrease in demand as well as uncertainty in the supply chain involved in the bioactive materials market.  It ultimately resulted in hindering the growth of the bioactive materials market during the COVID-19 pandemic. However, since economies are coming back on track after April 2022, the bioactive materials industry is anticipated to witness significant growth in the near future.  

Key Insights

The report will cover the following key insights:

• Regulatory Scenario of Market.


• Key developments in Bioactive Materials Industry.


• Impact of COVID-19 on Bioactive Materials Market.

Analysis by Material

Depending on the materials, global bioactive materials market is segmented into glass, ceramics, composites and others. The glass material segment held the significant share of the global market owing to the bioactivity and biocompatibility of the material as bonding agent. High share held by the glass material is also attributed to the higher demand for the matrrial for repairing and replacement of the broken or damaged bones. Developments in the field of medical engineering are anticipated to further propel the growth of bioactive glass materials market in the near future.

Analysis by Application

Depending on the application, market is segmented into orthopaedics, dentistry, pharmaceuticals & biotechnology and others. Among these, the dentistry segment held the significant share of the global market. High share of the dentistry is attributed to the rising consumer spending on dental care involving different treatments such as root canals. Increasing cases of dental treatments such as restoration of teeth, re-mineralization of teeth, pulp capping, etc. are anticipated to further push the demand of bioactive materials for applications in dentistry.

Regional Analysis

The global bioactive materials market has been categorized into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America holds the largest share of global bioactive materials industry owing to highly developed medical and healthcare industry in the region. In the recent past, the region has witnessed outstanding developments in the field of medical engineering, organ transplantation and dentistry. Continuous increase in the investment in the field of medical and healthcare is anticipated to boost the market in the region.

Europe holds a significant share of the global bioactive materials market. High growth of market in the region can be attributed to the significant development in the biomedical and healthcare sector. Rapidly progressing medical engineering and higher invetments in research and development sector are expected to propel the growth market in the tregion.

Asia Pacific is the fastest growing bioactive materials market owing to rapidly developing healthcare industry in the region. Developing economies in the region are increasing their medical and healthcare expenditure. Higher population of the region coupled with increasing health expenditure is anticipated to have considerable poisitive impact on the bioactive materials industry.   

Latin America and Middle East & Africa regions are expected to witness significant growth in the bioactive materials market. Increasing domestic as well as foreign investment in the field of medical and healthcatre industry is anticipated to play a significant role to drive the bioactive material market in the region.

Key Players Covered

The report will include the profiles of key players, such as Zimmer Holding Inc., Stryker Corporation, Medtronic Inc., Biomatlante, DePuy Synthes, Arthrex Inc., Bioactive Bone Substitutes Oy, Pulpdent Corporation, Noraker, Bioretec Ltd., Septodont Holding, and others.

Bioactive Materials Market Segmentation

Key Industry Developments

• In October 2022, Medtronic Inc., one of the global leaders in healthcare technology announced that it is separating its Respiratory Interventions and Patient Monitoring business, both are part of the Medical Surgical Portfolio of the company.


• In November 2021- Pulpdent Corporation, a major dental researcher and manufacturer, was awarded with two patents for stabilized calcium phosphate molecules by US Patent and Trademark Office.